• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drugs

  • Print
  • Share
  • E-mail
-

Crizotinib

Pharmacogenomic Information
  

Drug Link
in Drugs@FDA
Therapeutic Area Biomarker  Label Sections with
Pharmacogenomic
Information
Crizotinib Oncology ALK Indications and Usage
Warnings and Precautions
Adverse Reactions
Clinical Pharmacology
Clinical Studies

 

back to Pharmacogenomic Biomarkers in Drug Labels

-
-